Latest Comments on Ohad Hammer's Articles

1. tarlabgab on Cell Genesys: The Promise of GVAX: From what I understand lethal dose RT just prevent GVAX cell from... more »
2. Penn Bioinvestor on Incyte Presents Investors with Unique Dilemmas : INCY is one of the biotech stocks with great potential. Nice... more »
3. Ohad Hammer on Curagen: Positive Results at ASCO 2009: Sorry, cannot comment on that. more »
4. bio boy on Curagen: Positive Results at ASCO 2009: Ohad Hi What is your current opinion on GENZ and it's... more »
5. Furd Turgeson on Alimta: The 'Winner' of ASCO 2009: Allos has pralatrexate, which in my opinion will be the biggest... more »
6. Ohad Hammer on Peregrine Pharmaceuticals May Be On To Something: Let's wait for the data release at both conferences. The main... more »
7. topicviewer on Peregrine Pharmaceuticals May Be On To Something: From the evening wires: Just got picked for an oral... more »
8. hpski on Top Biotech Picks for ASCO 2009 (Part II): This is a follow up to my previous post. Genmab will indeed be... more »
9. hpski on Top Biotech Picks for ASCO 2009 (Part II): This is not an ASCO issue, however ASCO is overshadowing the... more »
10. Ohad Hammer on Top Biotech Picks for ASCO 2009 (Part I): As I wrote, the list is incomplete. Besides, most of the important... more »
11. Jonha's Pop on Top Biotech Picks for ASCO 2009 (Part I): Why is there no mention of ALTH ? more »
12. on avastin on Micromet: More Reasons for Optimism: my mistake. thanks for the clarification. On May 13 12:47 AM... more »
13. Ohad Hammer on Micromet: More Reasons for Optimism: I am not aware of a SGEN drug for ALL. They have drugs for all... more »
14. on avastin on Micromet: More Reasons for Optimism: is miti's ALL drug in the same patient population as SGEN's ALL... more »
15. Ohad Hammer on Micromet: More Reasons for Optimism: I think most of the negative sentiment can be attributed to the... more »